Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-27T14:34:03.623Z Has data issue: false hasContentIssue false
  • English
  • Français

The Prehospital Use of Albuterol Inhalation Treatments

Published online by Cambridge University Press:  28 June 2012

Eric A. Vonderohe ,
James H. Jones ,
Roland B. McGrath  and
Leon H. Bell
Eric A. Vonderohe
Affiliation:
Wright State University School of Medicine, Affiliated Residency in Emergency Medicine, Dayton, Ohio, USA
James H. Jones
Affiliation:
Wright State University School of Medicine, Affiliated Residency in Emergency Medicine, Dayton, Ohio, USA
Roland B. McGrath*
Affiliation:
Wright State University School of Medicine, Affiliated Residency in Emergency Medicine, Dayton, Ohio, USA
Leon H. Bell
Affiliation:
Wright State University School of Medicine, Affiliated Residency in Emergency Medicine, Dayton, Ohio, USA
*
Wright State University School of Medicine, Emergency Medicine Department, PO Box 927, Dayton OH 5401-0927 USA
Get access Rights & Permissions [Opens in a new window]

Abstract

The use of bronch odilators in the prehospital EMS setting is common. This study examined the safety of the administration of 2.5 mg albuterol using a hand-held nebulizer for the treatment of such patients.

A total of 55 patients were included. Following treatment, peak expiratory flow rates (PEFR) increased a mean of 27 L/min, ventilatory rate decreased four breaths/min, heart rate decreased slightly, and systolic blood pressure increased 10 mmHg. Five of the 53 patients in whom cardiac rhythm was monitored, had premature ventricular complexes prior to treatment; only one did following therapy. Breath sounds improved in 61% and were unchanged in 39%. Breathing was reported by the patient as improved in 51 of the 53 (93%) and only one felt worse. Adverse reactions were reported in 15%, but none were severe. This study shows that albuterol (2.5 mg) administration by hand-held nebulizer is both safe and efficacious in the prehospital setting.

Type
Brief Report
Information
Prehospital and Disaster Medicine , Volume 6 , Issue 3 , September 1991 , pp. 327 - 330
Copyright
Copyright © World Association for Disaster and Emergency Medicine 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Lazarus, S: Rational therapy of acute asthma. Ann Allergy 1989;63:585–590.Google ScholarPubMed
2. Rosen, R, Bone, R: Treatment of acute exacerbations in chronic obstructive pulmonary disease. Med Clin North Am 1990;74:691–700.Google Scholar
3. Schuster, M, Chong, J: Pharmacologic intervention in prehospital care: A critical appraisal. Ann Emerg Med 1989;18:192–196.Google Scholar
4. Hawkins, J, Hakala, K, et al. : Metered-dose aerosolized bronchodilators in prehospital care: A feasibility study. J Emerg Med 1986;4:273–277.CrossRefGoogle ScholarPubMed
5. Waeckerle, J, ed.: Abstracts of the 19th Annual Meeting of the Society for Academic Emergency Medicine. Ann Emerg Med 1989;18:435–482.Google Scholar
6. McEvoy, G, ed.: AHFS Drug Information. Bethesda, Md.: American Society of Hospital Pharmacists 1990, pp. 612–615.Google Scholar
7. Barnhart, E: Physicians’ Desk Reference. Oradel, NJ.: Medical Economics Company, 1990, 2014–2015.Google Scholar
8. Krome, R, ed.: Abstracts of the 18th Annual Meeting of the University Association for Emergency Medicine. Ann Emerg Med 1988;17:388–442.Google Scholar